Sang-Seol Jeon

Title: Inventor Spotlight: Sang-Seol Jeon from Gyeonggi-do, KR

Introduction

Sang-Seol Jeon is a prominent inventor based in Gyeonggi-do, South Korea, known for his contributions to the field of pharmaceutical chemistry. With two patents to his name, he has made significant strides in the development of compounds targeting protein kinases, which play a crucial role in various cellular processes.

Latest Patents

Jeon’s latest patents focus on the synthesis of intermediates vital for creating selective inhibitors against protein kinases. His first patent details intermediates that are used to synthesize an aminopyrimidine derivative or its pharmaceutically acceptable salt, specifically aimed at inhibiting mutant epidermal growth factor receptors. This invention not only provides a method for the synthesis but also highlights novel intermediates essential to this process.

The second patent presents a new method for preparing aminopyrimidine derivatives, which also possess selective inhibitory activities against protein kinases, particularly for those associated with mutant epidermal growth factor receptors. Both patents emphasize his innovative approach to addressing significant medical challenges through chemistry.

Career Highlights

Sang-Seol Jeon currently works for Yuhan Corporation, a leading pharmaceutical company in South Korea. His role there allows him to further develop his research and bring his inventions to market, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Jeon has collaborated with notable colleagues, including Sang-Ho Oh and Ja-Heouk Khoo. Their joint efforts in research and development emphasize the importance of teamwork in achieving groundbreaking innovations in the pharmaceutical industry.

Conclusion

Sang-Seol Jeon’s work exemplifies the vital intersection of innovation and healthcare. His patents not only reflect his ingenuity but also promise to advance therapeutic techniques in treating conditions related to protein kinases. As he continues to develop new ideas, the impact of his contributions to medicine and technology can be expected to grow.